Literature DB >> 8877143

Detection of serum immunoglobulin M to human cytomegalovirus by western blotting correlates better with virological data than detection by conventional enzyme immunoassay.

T Lazzarotto1, G T Maine, P Del Monte, H Frush, K Shi, M P Landini.   

Abstract

Western blotting (immunoblotting) with proteins separated from purified human cytomegalovirus (HCMV) particles (viral WB) has repeatedly been shown to be a reliable and sensitive method for detecting HCMV-specific immunoglobulin M (IgM). The aim of the present work was to determine whether IgM detected by viral WB correlates with virological diagnosis better than conventional enzyme immunoassay (conv-EIA). The presence of an active HCMV infection was documented on the basis of isolation of virus from urine and/or saliva and on the basis of antigenemia and/or PCR with polymorphonuclear leukocytes for immunocompetent and immunocompromised subjects, respectively. The agreement observed between IgM detected by viral WB and the results obtained by virological detection of HCMV was significantly higher (88.7%) than the agreement of IgM detected by conv-EIA and virological results (67.5%).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877143      PMCID: PMC170414          DOI: 10.1128/cdli.3.5.597-600.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  21 in total

1.  Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection.

Authors:  D Gold; R Ashley; H H Handsfield; M Verdon; L Leach; J Mills; L Drew; L Corey
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

2.  IgM to human cytomegalovirus: comparison of two enzyme immunoassays and IgM reactivity to viral polypeptides detected by immunoblotting.

Authors:  M C Re; M P Landini
Journal:  J Clin Lab Anal       Date:  1989       Impact factor: 2.352

3.  Correlation between immunofluorescent detection of human cytomegalovirus immediate early antigens in polymorphonuclear leukocytes and viremia.

Authors:  M Grazia Revello; M Zavattoni; E Percivalle; P Grossi; G Gerna
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

4.  Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen.

Authors:  C A Gleaves; T F Smith; E A Shuster; G R Pearson
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

5.  IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.

Authors:  Y J Kraat; F S Stals; M H Christiaans; T Lazzarotto; M P Landini; C A Bruggeman
Journal:  J Med Virol       Date:  1996-03       Impact factor: 2.327

6.  Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction.

Authors:  N M Jiwa; G W Van Gemert; A K Raap; F M Van de Rijke; A Mulder; P F Lens; M M Salimans; F E Zwaan; W Van Dorp; M Van der Ploeg
Journal:  Transplantation       Date:  1989-07       Impact factor: 4.939

7.  Antibodies to human cytomegalovirus structural polypeptides during primary infection.

Authors:  M P Landini; E Rossier; H Schmitz
Journal:  J Virol Methods       Date:  1988-12       Impact factor: 2.014

8.  Prokaryotic expression of immunogenic polypeptides of the large phosphoprotein (pp150) of human cytomegalovirus.

Authors:  B C Scholl; J Von Hintzenstern; B Borisch; B Traupe; M Bröker; G Jahn
Journal:  J Gen Virol       Date:  1988-06       Impact factor: 3.891

9.  Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes.

Authors:  W van der Bij; R Torensma; W J van Son; J Anema; J Schirm; A M Tegzess; T H The
Journal:  J Med Virol       Date:  1988-06       Impact factor: 2.327

10.  Kinetics of specific immunoglobulins M, E, A, and G in congenital, primary, and secondary cytomegalovirus infection studied by antibody-capture enzyme-linked immunosorbent assay.

Authors:  S L Nielsen; I Sørensen; H K Andersen
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

View more
  7 in total

1.  Search for cytomegalovirus-specific immunoglobulin M: comparison between a new western blot, conventional western blot, and nine commercially available assays.

Authors:  T Lazzarotto; S Brojanac; G T Maine; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Evaluation of a cytomegalovirus glycoprotein B recombinant enzyme immunoassay to discriminate between a recent and a past infection.

Authors:  M J Sipewa; P Goubau; M Bodéus
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

3.  Cytomegalovirus Reactivation in Ulcerative Colitis Patients.

Authors:  Minh Nguyen; Kara Bradford; Xiaolan Zhang; David Q Shih
Journal:  Ulcers       Date:  2011-01-01

4.  A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection.

Authors:  T Lazzarotto; G T Maine; P Dal Monte; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

5.  Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.

Authors:  G T Maine; R Stricker; M Schuler; J Spesard; S Brojanac; B Iriarte; K Herwig; T Gramins; B Combs; J Wise; H Simmons; T Gram; J Lonze; D Ruzicki; B Byrne; J D Clifton; L E Chovan; D Wachta; C Holas; D Wang; T Wilson; S Tomazic-Allen; M A Clements; G L Wright; T Lazzarotto; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

6.  Immunological response to cytomegalovirus in congenitally infected neonates.

Authors:  J Hassan; S Dooley; W Hall
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

7.  Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM.

Authors:  T Lazzarotto; A Ripalti; G Bergamini; M C Battista; P Spezzacatena; F Campanini; P Pradelli; S Varani; L Gabrielli; G T Maine; M P Landini
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.